Literature DB >> 24269812

27-Hydroxycholesterol induces recruitment of monocytic cells by enhancing CCL2 production.

Sun-Mi Kim1, Sae-A Lee, Bo-Young Kim, Sun-Sik Bae, Seong-Kug Eo, Koanhoi Kim.   

Abstract

Deposition of lipids in the intima is followed by infiltration of inflammatory cells, like monocytic cells and T lymphocytes, in atherosclerosis. However, roles of lipids in the infiltration of the inflammatory cells are not clearly defined. We investigated the possible involvement of cholesterol or its catabolites in recruitment of monocytic cells. Consumption of a high cholesterol-diet resulted in enhanced expression of CCL2 in arteries of ApoE(-/-) mice. 27-Hydroxycholesterol, the most abundant cholesterol oxide in atherosclerotic lesions, significantly induced the transcription of CCL2 and enhanced secretion of corresponding protein by THP-1 monocytic cells. However, cholesterol and 7-ketocholesterol did not influence expression of CCL2. Conditioned media containing CCL2 induced migration of monocytic cells, and migration was abrogated in the presence of CCL2-neutralizing antibody. TO-901317, a synthetic LXR agonist, inhibited both production of CCL2 and migration of monocytic cells induced by 27-hydroxycholesterol. Expression of CCL2 induced by 27-hydroxycholesterol was blocked when Akt inhibitor IV was added and when Akt1 was knocked down. We propose that 27-hydroxycholesterol will trigger a sequence of events leading to recruitment of monocytes into atherosclerotic lesions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemokines; Cholesterol oxides (oxysterols); Migration; Monocytic cells

Mesh:

Substances:

Year:  2013        PMID: 24269812     DOI: 10.1016/j.bbrc.2013.11.052

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Obesity, cholesterol metabolism, and breast cancer pathogenesis.

Authors:  Donald P McDonnell; Sunghee Park; Matthew T Goulet; Jeff Jasper; Suzanne E Wardell; Ching-Yi Chang; John D Norris; John R Guyton; Erik R Nelson
Journal:  Cancer Res       Date:  2014-07-24       Impact factor: 12.701

2.  Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer.

Authors:  Shui-Zhen Shi; Eun-Joon Lee; Ying-Jiong Lin; Lu Chen; Huai-Yu Zheng; Xiang-Qin He; Jing-Yi Peng; Satish K Noonepalle; Austin Y Shull; Felix C Pei; Li-Bin Deng; Xiao-Li Tian; Ke-Yu Deng; Huidong Shi; Hong-Bo Xin
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

3.  FSL-1, a Toll-like Receptor 2/6 Agonist, Induces Expression of Interleukin-1α in the Presence of 27-hydroxycholesterol.

Authors:  Weon Heo; Sun-Mi Kim; Seong-Kug Eo; Byung-Yong Rhim; Koanhoi Kim
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

4.  Dexamethasone inhibits activation of monocytes/macrophages in a milieu rich in 27-oxygenated cholesterol.

Authors:  Bo-Young Kim; Yonghae Son; Jeonga Lee; Jeongyoon Choi; Chi Dae Kim; Sun Sik Bae; Seong-Kug Eo; Koanhoi Kim
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

5.  PI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol.

Authors:  Yonghae Son; Bo-Young Kim; Young Chul Park; Seong-Kug Eo; Hyok-Rae Cho; Koanhoi Kim
Journal:  Korean J Physiol Pharmacol       Date:  2017-04-21       Impact factor: 2.016

Review 6.  Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway.

Authors:  Hélène Duez; Benoit Pourcet
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

7.  Dexamethasone Suppresses Oxysterol-Induced Differentiation of Monocytic Cells.

Authors:  Yonghae Son; Bo-Young Kim; Seong-Kug Eo; Young Chul Park; Koanhoi Kim
Journal:  Oxid Med Cell Longev       Date:  2016-05-31       Impact factor: 6.543

8.  The impact of 27-hydroxycholesterol on endometrial cancer proliferation.

Authors:  Douglas A Gibson; Frances Collins; Fiona L Cousins; Arantza Esnal Zufiaurre; Philippa T K Saunders
Journal:  Endocr Relat Cancer       Date:  2018-01-25       Impact factor: 5.678

9.  Prednisolone suppresses the immunostimulatory effects of 27-hydroxycholesterol.

Authors:  Bo-Young Kim; Yonghae Son; Min Su Kim; Koanhoi Kim
Journal:  Exp Ther Med       Date:  2020-01-16       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.